Literature DB >> 6734223

Cellular defense in critically ill surgical patients.

J A Bradley, D N Hamilton, M W Brown, W Cance, V S Jackson, I M Ledingham.   

Abstract

Cell-mediated immunity was examined using 4 recall antigens in 102 critically ill surgical patients treated in an ICU. There were 4 (14%) deaths in 28 patients with positive reactions (R), compared to 33 (45%) deaths in 74 nonreactors (NR) (p less than .01). Thirty-seven of the patients were admitted after trauma, and mortality in this group was not significantly different between R and NR patients. Repeat testing in 40 NR patients who remained in the ICU for more than 7 days showed that 30 remained NR (70% mortality) and 10 became R (20% mortality, p less than .001). Peripheral blood lymphocytes from the patients showed a reduced response to concanavalin A, but a normal response to phytohemagglutinin and pokeweed mitogen. Mononuclear cells and granulocytes both showed a small increase in chemotactic response to casein, suggesting that the reduced response to skin testing may be partly due to defective T-cell function, rather than impaired phagocyte chemotaxis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6734223     DOI: 10.1097/00003246-198407000-00004

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  3 in total

1.  Delayed-type hypersensitivity in surgical patients.

Authors:  L D MacLean
Journal:  Ann Surg       Date:  1987-06       Impact factor: 12.969

2.  Does intraoperative analgesia modify the immune response in surgical patients?

Authors:  Mahito Yamaguchi; Ryo Ogawa
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

Review 3.  Management of invasive candidiasis in critically ill patients.

Authors:  Stijn Blot; Koenraad Vandewoude
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.